Imagion Biosystems Limited

OTC: IBXXF · Healthcare · Medical - Diagnostics & Research

PublicHQ San Diego, CA · San DiegoReports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 34

v0.1 · 5/100 weight · pillars only

↑ Piotroski F, market scale · ↓ Altman-Z, listing tenure

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

as of 2026-09-21

Market cap

$6.5M

as of 2026-09-21

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue—0 AUD2025

Net income—-4.3M AUD2025

Operating income—-3.6M AUD2025

Total assets—2.0M AUD2025

Liabilities—4.2M AUD2025

Equity—-2.2M AUD2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Imagion Biosystems Limited’s financial profile?

Imagion Biosystems Limited has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Reviva Pharmaceuticals Holdings, Inc.——Xcelerate Inc.——LianBio——Curanex Pharmaceuticals Inc Common Stock——CalciMedica, Inc.——Cardiac Biotech Solutions Inc.——

Neighbors

San Diego →

QUALCOMM Incorporated$44.3B79B+Realty Income Corporation$5.7B61C Sempra$12.4B63C DexCom, Inc.$4.7B87A ResMed Inc.$5.1B——Illumina, Inc.$4.3B84B+

Key facts

CEORobert Romeo Proulx

SectorHealthcare

IndustryMedical - Diagnostics & Research

HeadquartersSan Diego, CA

ExchangeOTC: IBXXF

Employees11

IPO date2020-09-21

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.